Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809445 · ClinicalTrials.gov registry record · Phase 3
Rapid HIV Testing and Counseling in Drug Abuse Treatment
A Phase 3 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,281
- Enrollment target
NCT00809445: Completed Phase 3 study, sponsored by University of Miami.
NCT00809445 is a Phase 3 study that has completed, run by University of Miami. The registered enrollment target is 1,281 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00809445, a Phase 3 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,281 participants
- Enrollment target
Study Summary
This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV risk behaviors.
Primary Outcome
The HIV testing primary outcome is self-reported receipt of HIV test results. This will be measured at one month post-randomization for all participants. We recognize that there are three potential HIV testing behaviors that could be evaluated in this study: acceptance of HIV testing, completion of HIV testing, and receipt of HIV testing results. Acceptance of testing refers to whether or not a participant would accept the offer of an HIV test. Completion of testing refers to whether or not a pa
Interventions
- BEHAVIORAL On-site HIV rapid test and brief, prevention counseling
- BEHAVIORAL On- site HIV rapid test & information
- BEHAVIORAL Referral for off-site HIV testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,281 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
What the finished NCT00809445 record still lists
NCT00809445 is an interventional study that assigns participants to a tested intervention. Its 1,281 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (66% higher).
The record links to 0 conditions, and to 3 interventions - of which On-site HIV rapid test and brief, prevention counseling is the first listed.
NCT00809445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00809445 about?
NCT00809445 is a clinical study titled "Rapid HIV Testing and Counseling in Drug Abuse Treatment". This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt o...
What is the current status of trial NCT00809445?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,281 participants. The study started on 2009-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00809445?
The interventions under investigation include: On-site HIV rapid test and brief, prevention counseling (BEHAVIORAL), On- site HIV rapid test & information (BEHAVIORAL), Referral for off-site HIV testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00809445?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00809445's enrollment target sits among peer trials
1,281 198th of 2000 higher than 1,803 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia